Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland

Show simple item record

dc.contributor.author Murphy, Aileen
dc.contributor.author Kirby, Ann
dc.contributor.author Bradley, Colin P.
dc.date.accessioned 2018-09-27T12:08:18Z
dc.date.available 2018-09-27T12:08:18Z
dc.date.issued 2018
dc.identifier.citation Murphy, A., Kirby, A. and Bradley, C. (2018) 'Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland', BMC Research Notes, 11(1), 478 (6pp). doi:10.1186/s13104-018-3597-x en
dc.identifier.volume 11
dc.identifier.startpage 1
dc.identifier.endpage 6
dc.identifier.issn 1756-0500
dc.identifier.uri http://hdl.handle.net/10468/6933
dc.identifier.doi 10.1186/s13104-018-3597-x
dc.description.abstract Objective: New oral anticoagulants (NOACs) aim to overcome warfarin’s shortcomings, however their pharmacokinetic characteristics make prescribing complex. Thus it is imperative that general practitioners (GPs) are aware of specific treatments so as to maximise their benefits and minimise their pitfalls. This study explores GPs attitudes and experiences with prescribing NOACs in Ireland where, despite clear national prescribing guidelines advocating warfarin as first line therapy, the number of patients being prescribed NOACs for the first time is growing. Results: Using primary data collected from GPs in Ireland the factors influencing the likelihood of a GP initiating a prescription for a NOAC are determined using a probit model. Results indicate 46% of the sample initiated NOAC prescriptions and GP practice size is a significant factor influencing this. Analysis revealed no difference regarding the sources of information considered important amongst GPs when prescribing new drugs. However, there were differences in which factors were considered important when prescribing anticoagulants between initiating and non-initiating NOAC prescribers. The results of this study suggest better utilisation of existing information and education tools for GPs prescribing NOACs and managing NOAC patients is imperative, to ensure the right anticoagulant is prescribed for the right patient at the right time. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher BioMed Central Ltd. en
dc.relation.uri https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-018-3597-x
dc.rights © 2018, the Author(s). Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. en
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.subject Anticoagulation en
dc.subject Prescribing decisions en
dc.subject Education en
dc.subject Primary care en
dc.title Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Aileen Murphy, Economics, University College Cork, Cork, Ireland. +353-21-490-3000 Email: aileen.murphy@ucc.ie en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.description.status Peer reviewed en
dc.identifier.journaltitle BMC Research Notes en
dc.internal.IRISemailaddress aileen.murphy@ucc.ie en
dc.identifier.articleid 478


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2018, the Author(s). Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Except where otherwise noted, this item's license is described as © 2018, the Author(s). Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement